Jim Klostergaard - Publications

The University of Texas Graduate School of Biomedical Sciences at Houston 
Molecular Biology, Oncology

59 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Liang Y, Yu D, Perez-Soler R, Klostergaard J, Zou Y. TRIB2 contributes to cisplatin resistance in small cell lung cancer. Oncotarget. 8: 109596-109608. PMID 29312632 DOI: 10.18632/Oncotarget.22741  0.423
2015 Sahin IH, Klostergaard J. CD44 as a drug delivery target in human cancers: where are we now? Expert Opinion On Therapeutic Targets. 19: 1587-91. PMID 26374284 DOI: 10.1517/14728222.2015.1088834  0.325
2012 Lee SJ, Ghosh SC, Han HD, Stone RL, Bottsford-Miller J, Shen de Y, Auzenne EJ, Lopez-Araujo A, Lu C, Nishimura M, Pecot CV, Zand B, Thanapprapasr D, Jennings NB, Kang Y, ... ... Klostergaard J, et al. Metronomic activity of CD44-targeted hyaluronic acid-paclitaxel in ovarian carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 4114-21. PMID 22693353 DOI: 10.1158/1078-0432.Ccr-11-3250  0.356
2012 Klostergaard J, Seeney CE. Magnetic nanovectors for drug delivery. Nanomedicine : Nanotechnology, Biology, and Medicine. 8: S37-50. PMID 22640907 DOI: 10.1016/J.Nano.2012.05.010  0.34
2012 Ghosh SC, Neslihan Alpay S, Klostergaard J. CD44: a validated target for improved delivery of cancer therapeutics. Expert Opinion On Therapeutic Targets. 16: 635-50. PMID 22621669 DOI: 10.1517/14728222.2012.687374  0.402
2012 Klostergaard J, Seeney CE. Magnetic nanovectors for drug delivery. Maturitas. 73: 33-44. PMID 22402027 DOI: 10.1016/J.Maturitas.2012.01.019  0.34
2012 Seeney C, Ojwang JO, Weiss RD, Klostergaard J. Magnetically vectored platforms for the targeted delivery of therapeutics to tumors: history and current status. Nanomedicine (London, England). 7: 289-99. PMID 22339137 DOI: 10.2217/Nnm.11.183  0.333
2012 Chen X, Fokt I, Skora S, Priebe W, Bi Y, Tang DG, Yan H, Zhang Q, Qin J, Li H, Liu C, Davis T, Coletta LD, Klostergaard J. Abstract C65: Drug-tolerant cancer cells show reduced tumor-initiating capacity: Depletion of CD44+ cells and evidence for epigenetic mechanisms Cancer Research. 72: C65-C65. DOI: 10.1158/1538-7445.Prca2012-C65  0.429
2011 Yan H, Chen X, Zhang Q, Qin J, Li H, Liu C, Calhoun-Davis T, Coletta LD, Klostergaard J, Fokt I, Skora S, Priebe W, Bi Y, Tang DG. Drug-tolerant cancer cells show reduced tumor-initiating capacity: depletion of CD44 cells and evidence for epigenetic mechanisms. Plos One. 6: e24397. PMID 21935404 DOI: 10.1371/Journal.Pone.0024397  0.429
2011 Galer CE, Sano D, Ghosh SC, Hah JH, Auzenne E, Hamir AN, Myers JN, Klostergaard J. Hyaluronic acid-paclitaxel conjugate inhibits growth of human squamous cell carcinomas of the head and neck via a hyaluronic acid-mediated mechanism Oral Oncology. 47: 1039-1047. PMID 21903450 DOI: 10.1016/J.Oraloncology.2011.07.029  0.42
2011 McMurray JS, Klostergaard J, Robertson FM, Mandal PK, Auzenne EJ, Liao WS. Abstract B8: Selective inhibition of Stat3 Tyr705 phosphorylation inhibits angiogenesis in breast cancer xenografts. Molecular Cancer Therapeutics. 10. DOI: 10.1158/1535-7163.Targ-11-B8  0.366
2010 Somasunderam A, Thiviyanathan V, Tanaka T, Li X, Neerathilingam M, Lokesh GLR, Mann A, Peng Y, Ferrari M, Klostergaard J, Gorenstein DG. Combinatorial selection of DNA thioaptamers targeted to the HA binding domain of human CD44 Biochemistry. 49: 9106-9112. PMID 20843027 DOI: 10.1021/Bi1009503  0.306
2009 Khodadadian M, Leroux ME, Auzenne E, Ghosh SC, Farquhar D, Evans R, Spohn W, Zou Y, Klostergaard J. MRP- and BCL-2-mediated drug resistance in human SCLC: Effects of apoptotic sphingolipids in vitro Lung Cancer. 66: 48-57. PMID 19195736 DOI: 10.1016/J.Lungcan.2009.01.006  0.679
2009 Ghosh SC, Auzenne E, Khodadadian M, Farquhar D, Klostergaard J. N,N-Dimethylsphingosine conjugates of poly-L-glutamic acid: synthesis, characterization, and initial biological evaluation. Bioorganic & Medicinal Chemistry Letters. 19: 1012-7. PMID 19097786 DOI: 10.1016/J.Bmcl.2008.11.079  0.377
2007 Leroux ME, Auzenne E, Evans R, Hail N, Spohn W, Ghosh SC, Farquhar D, McDonnell TJ, Klostergaard J. Sphingolipids and the sphingosine kinase inhibitor, SKI II, induce BCL-2-independent apoptosis in human prostatic adenocarcinoma cells. The Prostate. 67: 1699-1717. PMID 17879964 DOI: 10.1002/Pros.20645  0.676
2007 Auzenne E, Ghosh SC, Khodadadian M, Rivera B, Farquhar D, Price RE, Ravoori M, Kundra V, Freedman RS, Klostergaard J. Hyaluronic acid-paclitaxel: antitumor efficacy against CD44(+) human ovarian carcinoma xenografts. Neoplasia (New York, N.Y.). 9: 479-86. PMID 17603630 DOI: 10.1593/Neo.07229  0.385
2007 Ghosh SC, Auzenne E, Farquhar D, Klostergaard J. N,N-dimethylsphingosine-coumarin: synthesis, chemical characterization, and biological evaluation. Bioconjugate Chemistry. 18: 731-5. PMID 17432826 DOI: 10.1021/Bc060285Q  0.32
2007 Klostergaard J, Bankson J, Auzenne E, Gibson D, Yuill W, Seeney CE. Magnetic vectoring of magnetically responsive nanoparticles within the murine peritoneum Journal of Magnetism and Magnetic Materials. 311: 330-335. DOI: 10.1016/J.Jmmm.2006.10.1163  0.308
2006 Klostergaard J, Leroux ME, Auzenne E, Khodadadian M, Spohn W, Wu JY, Donato NJ. Hyperthermia engages the intrinsic apoptotic pathway by enhancing upstream caspase activation to overcome apoptotic resistance in MCF‐7 breast adenocarcinoma cells Journal of Cellular Biochemistry. 98: 356-369. PMID 16440323 DOI: 10.1002/Jcb.20729  0.44
2004 Zou Y, Fu H, Ghosh S, Farquhar D, Klostergaard J. Antitumor activity of hydrophilic Paclitaxel copolymer prodrug using locoregional delivery in human orthotopic non-small cell lung cancer xenograft models. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 7382-91. PMID 15534115 DOI: 10.1158/1078-0432.Ccr-04-0334  0.365
2004 Donato NJ, Klostergaard J. Distinct stress and cell destruction pathways are engaged by TNF and ceramide during apoptosis of MCF-7 cells. Experimental Cell Research. 294: 523-33. PMID 15023539 DOI: 10.1016/J.Yexcr.2003.11.021  0.46
2002 Jendiroba DB, Klostergaard J, Keyhani A, Pagliaro L, Freireich EJ. Effective cytotoxicity against human leukemias and chemotherapy-resistant leukemia cell lines by N-N-dimethylsphingosine. Leukemia Research. 26: 301-10. PMID 11792420 DOI: 10.1016/S0145-2126(01)00129-1  0.422
2002 Deng J, Zhang H, Kloosterboer F, Liao Y, Klostergaard J, Levitt ML, Hung MC. Ceramide does not act as a general second messenger for ultraviolet-induced apoptosis. Oncogene. 21: 44-52. PMID 11791175 DOI: 10.1038/Sj.Onc.1204900  0.42
2001 Utsumi T, Takeshige T, Tanaka K, Takami K, Kira Y, Klostergaard J, Ishisaka R. Transmembrane TNF (pro-TNF) is palmitoylated Febs Letters. 500: 1-6. PMID 11434916 DOI: 10.1016/S0014-5793(01)02576-5  0.364
2001 Leroux E, Auzenne E, Weidner D, Wu ZY, Donato NJ, Klostergaard J. Febrile and acute hyperthermia enhance TNF-induced necrosis of murine L929 fibrosarcoma cells via caspase-regulated production of reactive oxygen intermediates. Journal of Cellular Physiology. 187: 256-263. PMID 11268005 DOI: 10.1002/Jcp.1074  0.405
2000 Mehta S, Blackinton D, Omar I, Kouttab N, Myrick D, Klostergaard J, Wanebo H. Combined cytotoxic action of paclitaxel and ceramide against the human Tu138 head and neck squamous carcinoma cell line. Cancer Chemotherapy and Pharmacology. 46: 85-92. PMID 10972477 DOI: 10.1007/S002800000140  0.422
1999 Ishisaka R, Sato N, Tanaka K, Takeshige T, Iwata H, Klostergaard J, Utsumi T. A part of the transmembrane domain of pro-TNF can function as a cleavable signal sequence that generates a biologically active secretory form of TNF. Journal of Biochemistry. 126: 413-420. PMID 10423538 DOI: 10.1093/Oxfordjournals.Jbchem.A022466  0.315
1999 Myrick D, Blackinton D, Klostergaard J, Kouttab N, Maizel A, Wanebo H, Mehta S. Paclitaxel-induced apoptosis in Jurkat, a leukemic T cell line, is enhanced by ceramide. Leukemia Research. 23: 569-578. PMID 10374850 DOI: 10.1016/S0145-2126(99)00048-X  0.43
1998 Klostergaard J, Auzenne E, Leroux E. Characterization of cytotoxicity induced by sphingolipids in multidrug-resistant leukemia cells Leukemia Research. 22: 1049-1056. PMID 9783808 DOI: 10.1016/S0145-2126(98)00107-6  0.431
1998 Auzenne E, Leroux ME, Hu M, Pollock RE, Feig BW, Klostergaard J. Cytotoxic effects of sphingolipids as single or multi-modality agents on human melanoma and soft tissue sarcoma in vitro Melanoma Research. 8: 227-239. PMID 9664144 DOI: 10.1097/00008390-199806000-00005  0.42
1997 Balch G, Izzo F, Chiao P, Klostergaard J, Curley SA. Activation of human Kupffer cells by thymostimulin (TP-1) to produce cytotoxicity against human hepatocellular cancer. Annals of Surgical Oncology. 4: 149-55. PMID 9084852 DOI: 10.1007/Bf02303798  0.308
1996 Tang P, Hung MC, Klostergaard J. Length of the linking domain of human pro-tumor necrosis factor determines the cleavage processing. Biochemistry. 35: 8226-8233. PMID 8679577 DOI: 10.1021/Bi952183L  0.332
1996 Tang P, Hung MC, Klostergaard J. Human pro-Tumor Necrosis Factor Is a Homotrimer Biochemistry. 35: 8216-8225. PMID 8679576 DOI: 10.1021/Bi952182T  0.402
1996 Klostergaard J, Akimaru Y, Tomasovic SP. Step-down heating enhances the cytotoxicity of human tumour necrosis factor on murine and human tumour cell lines in vitro International Journal of Hyperthermia. 12: 97-114. PMID 8676012 DOI: 10.3109/02656739609023693  0.427
1996 Utsumi T, Kuranami J, Tou E, Ide A, Akimaru K, Hung MC, Klostergaard J. In vitro synthesis of an N-myristoylated fusion protein that binds to the liposomal surface. Archives of Biochemistry and Biophysics. 326: 179-184. PMID 8611021 DOI: 10.1006/Abbi.1996.0063  0.308
1995 Tang P, Hung MC, Klostergaard J. ADP-Ribosylation Inhibitors Inhibit Cellular RNA Synthesis but Do Not Affect Expression of Manganous Superoxide Dismutase or Heat Shock Protein 70 in Tumor Necrosis Factor αSensitive and -Resistant Tumor Cells Journal of Interferon and Cytokine Research. 15: 791-797. PMID 8536107 DOI: 10.1089/Jir.1995.15.791  0.418
1995 Klostergaard J, Leroux ME, Hsu HA, Hsi BP, Siddik ZH, Danhauser LL, Tomasovi SP. Multi-chemothermoimmunotherapy for human colon adenocarcinoma in vitro Cancer Chemotherapy and Pharmacology. 37: 235-241. PMID 8529283 DOI: 10.1007/Bf00688322  0.433
1995 Auzenne E, Feig BW, Ross MI, Tomasovic SP, Klostergaard J. Tetramodality treatment of human melanoma in vitro. Melanoma Research. 5: 49-57. PMID 7734956 DOI: 10.1097/00008390-199502000-00006  0.419
1995 Lodato RF, Feig B, Akimaru K, Soma G, Klostergaard J. Hemodynamic evaluation of recombinant human tumor necrosis factor (TNF)-α, TNF-SAM2 and liposomal TNF-SAM2 in an anesthetized dog model Journal of Immunotherapy. 17: 19-29. PMID 7728303 DOI: 10.1097/00002371-199501000-00003  0.35
1995 Lengyel E, Klostergaard J, Boyd D. Stimulation of urokinase expression by TNF-α requires the activation of binding sites for the AP-1 and PEA3 transcription factors Biochimica Et Biophysica Acta. 1268: 65-72. PMID 7626664 DOI: 10.1016/0167-4889(95)00050-3  0.331
1995 Klostergaard J, Akimaru K, Soma GI, Lodato RF. Development and Characterization of Liposomal Tumor Necrosis Factor (Tnf) Journal of Liposome Research. 5: 491-502. DOI: 10.3109/08982109509010238  0.383
1994 Tomasovic SP, Vasey TA, Story MD, Stephens LC, Klostergaard J. Cytotoxic manifestations of the interaction between hyperthermia and TNF: DNA fragmentation. International Journal of Hyperthermia. 10: 247-262. PMID 8064183 DOI: 10.3109/02656739409009346  0.352
1994 Tomasovic SP, Khodadadian M, Hung M, Klostergaard J. Hyperthermia enhances the cytotoxicity of National Institutes of Health 3T3 cells transfected with a noncleavable transmembrane pro-tumor necrosis factor deletion mutant. Journal of Immunotherapy. 16: 181-187. PMID 7834117 DOI: 10.1097/00002371-199410000-00002  0.462
1993 Curley SA, Roh MS, Feig BW, Oyedeji C, Kleinerman ES, Klostergaard J. Mechanisms of Kupffer cell cytotoxicity in vitro against the syngeneic murine colon adenocarcinoma line MCA26 Journal of Leukocyte Biology. 53: 715-721. PMID 8315355 DOI: 10.1002/Jlb.53.6.715  0.446
1992 Roh MS, Kahky MP, Oyedeji C, Klostergaard J, Wang L, Curley SA, Lotzová E. Murine Kupffer cells and hepatic natural killer cells regulate tumor growth in a quantitative model of colorectal liver metastases. Clinical & Experimental Metastasis. 10: 317-327. PMID 1505122 DOI: 10.1007/Bf00058171  0.34
1992 Tomasovic SP, Lu S, Klostergaard J. Comparative in vitro studies of the potentiation of tumor necrosis factor (TNF)-alpha, TNF-beta, and TNF-SAM2 cytotoxicity by hyperthermia. Journal of Immunotherapy. 11: 85-92. DOI: 10.1097/00002371-199202000-00002  0.38
1991 Tucker SD, Sivaramakrishnan MR, Klostergaard J, Lopez-Berestein G. Independence of the pattern of early cytokine release from autoregulation by nitric oxide Journal of Leukocyte Biology. 50: 509-516. PMID 1748844 DOI: 10.1002/Jlb.50.5.509  0.397
1990 Roh MS, Wang L, Oyedeji C, LeRoux ME, Curley SA, Pollock RE, Klostergaard J. Human Kupffer cells are cytotoxic against human colon adenocarcinoma Surgery. 108: 400-405. PMID 2382233 DOI: 10.1002/Bjs.1800770937  0.386
1990 Klostergaard J, Stoltje PA, Kull FC. Tumoricidal effector mechanisms of murine BCG-activated macrophages: Role of TNF in conjugation-dependent and conjugation-independent pathways Journal of Leukocyte Biology. 48: 220-228. PMID 2167918 DOI: 10.1002/Jlb.48.3.220  0.365
1989 Tomasovic SP, Klostergaard J. Hyperthermic modulation of macrophage-tumor cell interactions. Cancer and Metastasis Reviews. 8: 215-229. PMID 2697471 DOI: 10.1007/Bf00047338  0.342
1989 Klostergaard J, Leroux ME. L-Arginine independent macrophage tumor cytotoxicity Biochemical and Biophysical Research Communications. 165: 1262-1266. PMID 2692564 DOI: 10.1016/0006-291X(89)92738-1  0.336
1989 Tomasovic SP, Barta M, Klostergaard J. Temporal dependence of hyperthermic augmentation of macrophage-TNF production and tumor cell-TNF sensitization. International Journal of Hyperthermia. 5: 625-639. PMID 2671183 DOI: 10.3109/02656738909140486  0.342
1989 Savary CA, Lotzova E, Klostergaard J. Interleukin 2-activated large granular lymphocytes: cytotoxic efficiency and mechanism of killing of tumor cell lines. Immunology Letters. 21: 145-151. PMID 2670758 DOI: 10.1016/0165-2478(89)90051-5  0.337
1989 Tomasovic SP, Barta M, Klostergaard J. Neutral Red Uptake and Clonogenic Survival Assays of the Hyperthermic Sensitization of Tumor Cells to Tumor Necrosis Factor Radiation Research. 119: 325-337. DOI: 10.2307/3577623  0.421
1988 LaBiche RA, Yoshida M, Gallick GE, Irimura T, Robberson DL, Klostergaard J, Nicolson GL. Gene expression and tumor cell escape from host effector mechanisms in murine large cell lymphoma Journal of Cellular Biochemistry. 36: 393-403. PMID 3379107 DOI: 10.1002/Jcb.240360408  0.416
1987 Klostergaard J, Kilbourn RG, Foster WA, Lopez-Berestein G. Rapid, quantitative microassay for the monokine respiration inhibitory factor Journal of Immunological Methods. 101: 97-108. PMID 3112239 DOI: 10.1016/0022-1759(87)90222-5  0.348
1986 Souchek JM, Leroux ME, Klostergaard J. Sensitization of tumor target cells to cytolysis by murine macrophage cytolytic factor by drugs inhibiting DNA, RNA, and protein synthesis. Journal of Leukocyte Biology. 40: 755-768. PMID 3465837 DOI: 10.1002/Jlb.40.6.755  0.382
1985 Armstrong CA, Klostergaard J, Granger GA. Isolation and Initial Characterization of Tumoricidal Monokine(s) From the Human Monocytic Leukemia Cell Line THP-1 Journal of the National Cancer Institute. 74: 1-9. DOI: 10.1093/Jnci/74.1.1  0.376
1983 Miner KM, Klostergaard J, Granger GA, Nicolson GL. Differences in Cytotoxic Effects of Activated Murine Peritoneal Macrophages and J774 Monocytic Cells on Metastatic Variants of B16 Melanoma Journal of the National Cancer Institute. 70: 717-724. DOI: 10.1093/Jnci/70.4.717  0.383
Show low-probability matches.